Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study

• Main Authors: Andrea Lombardi (Author), Giacomo M. Butta (Author), Lorena Donnici (Author), Giorgio Bozzi (Author), Massimo Oggioni (Author), Patrizia Bono (Author), Malvina Matera (Author), Dario Consonni (Author), Serena Ludovisi (Author), Antonio Muscatello (Author), Ferruccio Ceriotti (Author), Matteo Conti (Author), Susanna Scaglioni (Author), Greta Gallo (Author), Edoardo Scarpa (Author), Michael Letko (Author), Sergio Abrignani (Author), Renata Grifantini (Author), Raffaele De Francesco (Author), Andrea Gori (Author), Lara Manganaro (Author), Alessandra Bandera (Author)
• Format: Book
• Published: Elsevier, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Vaccines against COVID-19 are a powerful tool to control the current SARS-CoV-2 pandemic. A thorough description of their immunogenicity among people living with HIV (PLWHIV) is necessary. We aimed to assess the immunogenicity of the mRNA-1273 vaccine among PLWHIV. Methods: In t...